In Silico Analysis of Metabolites from Peruvian Native Plants as Potential Therapeutics against Alzheimer's Disease
- PMID: 35164183
- PMCID: PMC8838509
- DOI: 10.3390/molecules27030918
In Silico Analysis of Metabolites from Peruvian Native Plants as Potential Therapeutics against Alzheimer's Disease
Abstract
Background: Despite research on the molecular bases of Alzheimer's disease (AD), effective therapies against its progression are still needed. Recent studies have shown direct links between AD progression and neurovascular dysfunction, highlighting it as a potential target for new therapeutics development. In this work, we screened and evaluated the inhibitory effect of natural compounds from native Peruvian plants against tau protein, amyloid beta, and angiotensin II type 1 receptor (AT1R) pathologic AD markers.
Methods: We applied in silico analysis, such as virtual screening, molecular docking, molecular dynamics simulation (MD), and MM/GBSA estimation, to identify metabolites from Peruvian plants with inhibitory properties, and compared them to nicotinamide, telmisartan, and grapeseed extract drugs in clinical trials.
Results: Our results demonstrated the increased bioactivity of three plants' metabolites against tau protein, amyloid beta, and AT1R. The MD simulations indicated the stability of the AT1R:floribundic acid, amyloid beta:rutin, and tau:brassicasterol systems. A polypharmaceutical potential was observed for rutin due to its high affinity to AT1R, amyloid beta, and tau. The metabolite floribundic acid showed bioactivity against the AT1R and tau, and the metabolite brassicasterol showed bioactivity against the amyloid beta and tau.
Conclusions: This study has identified molecules from native Peruvian plants that have the potential to bind three pathologic markers of AD.
Keywords: Alzheimer’s disease; Peru; Peruvian native plants; brassicasterol; floribundic acid; in silico; polypharmacology; rutin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Amin F., Shamsi A., Asghar M.N., Khaki P.S.S., Khan M.S., Tabrez S., Zaidi S.K., Khan W., Bano B. Biological, Diagnostic and Therapeutic Advances in Alzheimer’s Disease. Springer; Berlin/Heidelberg, Germany: 2019. Alzheimer’s: A Progressive Brain Disease: Causes, Symptoms, and Prevention; pp. 31–51.
-
- Taipa R., Ferreira V., Brochado P., Robinson A., Reis I., Marques F., Mann D.M., Melo-Pires M., Sousa N. Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: A post mortem study. Neuropathol. Appl. Neurobiol. 2018;44:298–313. doi: 10.1111/nan.12445. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
